Dr. Zhao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-745-9200- Is this information wrong?
Summary
- Dr. Dan Zhao is an oncologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. She received her education from Tongji Medical College and Peking Union Medical College has been in practice 12 years. She also speaks multiple languages, including Chinese (Mandarin). She specializes in gastrointestinal cancer and is experienced in gastrointestinal cancer including pancreatic cancer, immunotherapy, targeted therapy, and clinical cancer research.
Education & Training
- City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
- One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Internal Medicine, 2014 - 2017
- Massachusetts General HospitalOncology, Translational cancer research, 2012 - 2014
- National Cancer InstitutePost-Doctoral Fellowship, Cancer and Inflammation Program, 2009 - 2012
- Peking Union Medical CollegeClass of 2009, PhD, Oncology
- Tongji Medical CollegeMD, 1999 - 2004
Certifications & Licensure
- FL State Medical License 2021 - Present
- GA State Medical License 2022 - 2026
- WA State Medical License 2022 - 2025
- TX State Medical License 2020 - 2025
- CA State Medical License 2017 - 2025
- TN State Medical License 2022 - 2025
- LA State Medical License 2022 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Awards, Honors, & Recognition
- First Prize of Natural Science Award Ministry of Education, China, 2012
- Third Prize of Medical Science and Technology Award Chinese Medical Association, 2012
- Second Prize of Science and Technology Award Beijing City, China, 2012
- Join now to see all
Clinical Trials
- Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers Start of enrollment: 2020 Oct 23
- Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients Start of enrollment: 2023 May 03
Publications & Presentations
PubMed
- 2 citationsImpact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury, Kawther Abdilleh, Mark Knafl, Paul Edelkamp, Kristin Alfaro-Munoz, Ray Chacko, Jennifer Peterson, Brandon G Smagl...> ;NPJ Precision Oncology. 2024 Feb 3
- 2 citationsPneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors.Gabriel Sperling, Malek Shatila, Krishnavathan Varatharajalu, Yang Lu, Mehmet Altan, Yan Zhou, Dan Zhao, Enrico N De Toni, Helga-Paula Török, Bryan J Schneider, Anam K...> ;Journal of Cancer Research and Clinical Oncology. 2023 Dec 1
- Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant...Tom Z Liang, Matthew H G Katz, Laura R Prakash, Deyali Chatterjee, Hua Wang, Michael Kim, Ching-Wei D Tzeng, Naruhiko Ikoma, Robert A Wolff, Dan Zhao, Eugene J Koay, A...> ;Cancers. 2023 Jun 18
- Join now to see all
Journal Articles
- Updates on Immunotherapy for the Treatment of Skin Cancer.Kang A, Zhao D, Yeh JJ, Lee DJ., Current Dermatology Reports., 2018
Books/Book Chapters
Abstracts/Posters
- JNJ-61186372, a Human Bispecific EGFR and cMet Antibody, in Primary MET Exon14 Skipping Non-Small Cell Lung CancerDan Zhao MD, PhD, Meena Thayu MD, Martin Shreeve MD, PhD, Roland Knoblauch MD, PhD, Joshua Curtin PhD, Amy Roshak BS, Matthew Lorenzi Ph, Ravi Salgia, MD, PhD, Marian..., IASLC Targeted Therapies of Lung Cancer Meeting 2020, Santa Monica, CA
- Evaluation of immune-related adverse events in patients treated with sequential immunotherapy and tyrosine kinase inhibitor treatment in non-small cell lung cancerAngel Ray Baroz, Isa Mambetsariev, Jeremy Fricke, Rebecca Pharaon, Dan Zhao, Marianna Koczywas, Erminia Massarelli, Ravi Salgia, Journal of Clinical Oncology 2020 38:15_suppl, e21562-e21562, ASCO 2020
- Molecular and clinical features of hospital admissions and immunotherapy related adverse events of immune checkpoint inhibitors in thoracic malignanciesDan Zhao MD, PhD, Haiqing Li PhD, Isa Mambestariev BA, Chen Chen MS, Jeremy Fricke BS, Prakash Kulkarni PhD, Yan Xing MD PhD, Erminia Massarelli MD PhD, Marianna Koczy..., ASCO annual meeting 2019, Chichago, IL
- Join now to see all
Press Mentions
- Experimental Drugs That Change Energy Supply in Cells Could Slow Brain Tumor GrowthMay 27th, 2020
- Genetic Mutations in Pancreatic Cancer Are Paving the Way for a Potential VaccineFebruary 15th, 2024
Professional Memberships
- Member
- Member
- Member
- Society for Immunotherapy of Cancer (SITC)Member
Other Languages
- Chinese (Mandarin)
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
External Links
- My Bibliographyhttps://www.ncbi.nlm.nih.gov/myncbi/1xufSnl5Bzq5co/bibliography/public/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: